Identification of residues in VP2 that contribute to poliovirus neutralization antigenic site 3B
- PMID: 1714663
- DOI: 10.1016/0042-6822(91)90856-7
Identification of residues in VP2 that contribute to poliovirus neutralization antigenic site 3B
Abstract
Amino acid substitutions were placed at residues 74, 243, and 246 in capsid protein VP2 of poliovirus serotype 1, using site-specific mutagenesis methods. The proximity of these residues to those previously identified in neutralization site 3B suggests that these residues may also contribute to neutralization site 3B and potentially be under antibody selective pressure to mutate. However, sequence analyses of independent serotype 1 isolates indicate high sequence conservation at these residues, suggesting selective pressures are present within the virus to maintain sequences within these loop regions. All viable mutants display partial or complete resistance to neutralization by the site 3B neutralizing monoclonal antibodies. Cross-neutralization data with the site-specifically generated viral mutants confirm that these residues do indeed contribute to forming neutralization site 3B and also identify the participation of a new loop region within site 3B. However, many amino acid substitutions generate nonviable virus mutants and even conservative amino acid substitutions produce growth-compromised virus mutants. These data suggest that previous definition of neutralization antigenic sites by isolation of neutralization resistant mutants favors detection of viable mutant viruses with more normal growth characteristics and is inherently biased against detection of neutralization antigenic sites formed by residues critical for other stages of virus replication.
Similar articles
-
Molecular basis for linkage of a continuous and discontinuous neutralization epitope on the structural polypeptide VP2 of poliovirus type 1.J Virol. 1990 Mar;64(3):1283-9. doi: 10.1128/JVI.64.3.1283-1289.1990. J Virol. 1990. PMID: 1689392 Free PMC article.
-
Antigenic structure of polioviruses of serotypes 1, 2 and 3.J Gen Virol. 1986 Jul;67 ( Pt 7):1283-91. doi: 10.1099/0022-1317-67-7-1283. J Gen Virol. 1986. PMID: 2425046
-
Identification of the location of antigenic sites of swine vesicular disease virus with neutralization-resistant mutants.J Gen Virol. 1995 Dec;76 ( Pt 12):3099-106. doi: 10.1099/0022-1317-76-12-3099. J Gen Virol. 1995. PMID: 8847515
-
Antibody recognition of picornaviruses and escape from neutralization: a structural view.Virus Res. 1995 Sep;38(1):1-24. doi: 10.1016/0168-1702(95)00048-u. Virus Res. 1995. PMID: 8546007 Review.
-
Mechanisms of neutralization of animal viruses: monoclonal antibodies provide a new perspective.Microb Pathog. 1988 Jul;5(1):1-7. doi: 10.1016/0882-4010(88)90075-7. Microb Pathog. 1988. PMID: 2854186 Review. No abstract available.
Cited by
-
Is the 135S poliovirus particle an intermediate during cell entry?J Virol. 2000 Sep;74(18):8757-61. doi: 10.1128/jvi.74.18.8757-8761.2000. J Virol. 2000. PMID: 10954579 Free PMC article.
-
Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature.J Virol. 1994 Jun;68(6):3965-70. doi: 10.1128/JVI.68.6.3965-3970.1994. J Virol. 1994. PMID: 7514682 Free PMC article.
-
Antigenic and immunogenic properties of recombinant hepatitis A virus 14S and 70S subviral particles.J Virol. 1993 Feb;67(2):1080-5. doi: 10.1128/JVI.67.2.1080-1085.1993. J Virol. 1993. PMID: 7678298 Free PMC article.
-
Efficient analysis of nonviable poliovirus capsid mutants.J Virol. 1993 Mar;67(3):1734-8. doi: 10.1128/JVI.67.3.1734-1738.1993. J Virol. 1993. PMID: 8382319 Free PMC article.
-
Folding and processing of the capsid protein precursor P1 is kinetically retarded in neutralization site 3B mutants of poliovirus.J Virol. 1992 Mar;66(3):1641-8. doi: 10.1128/JVI.66.3.1641-1648.1992. J Virol. 1992. PMID: 1310770 Free PMC article.